Ledger.Open graph →
SEC Form D · filed March 26, 2014

FIVE PRIME THERAPEUTICS INC

Offering
$21.0M
Sold
$21.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Mark D. Mcdade · South San Francisco, CADirectorW. M. Kavanaugh, M.D · South San Francisco, CAExecBrian G. Atwood · South San Francisco, CADirectorR. L. Douglas · South San Francisco, CADirectorFrancis W. Sarena · South San Francisco, CAExecAron M. Knickerbocker · South San Francisco, CAExec · DirectorFred E. Cohen, M.D., D.Phil · South San Francisco, CADirectorFranklin M. Berger, Cfa · South San Francisco, CADirectorJulie L. Hambleton, M.D · South San Francisco, CAExecLewis T. Williams · San Francisco, CAExec · DirectorPeder K. Jensen, M.D · South San Francisco, CADirectorMarc L. Belsky · South San Francisco, CAExecMark D. Mcdade · South San Francisco, CADirectorW. M. Kavanaugh, M.D · South San Francisco, CAExecBrian G. Atwood · South San Francisco, CADirectorR. L. Douglas · South San Francisco, CADirectorFred E. Cohen, M.D., D.Phil · South San Francisco, CADirectorFranklin M. Berger, Cfa · South San Francisco, CADirectorJulie L. Hambleton, M.D · South San Francisco, CAExecFrancis W. Sarena · South San Francisco, CAExecLewis T. Williams · South San Francisco, CAExec · DirectorPeder K. Jensen, M.D · South San Francisco, CADirectorAron M. Knickerbocker · South San Francisco, CAExec · DirectorMarc L. Belsky · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗